Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38376 - 38400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ROBO2	6092	downregulated	entinostat results in decreased expression of ROBO2 mRNA	3p12.3	A21037
Entinostat	Investigational	ROR1	4919	upregulated	entinostat results in increased expression of ROR1 mRNA	1p31.3	A21037
Entinostat	Investigational	RPAIN	84268	downregulated	entinostat results in decreased expression of RPAIN mRNA	17p13.2	A21035
Entinostat	Investigational	RPH3AL	9501	downregulated	entinostat results in decreased expression of RPH3AL mRNA	17p13.3	A21037
Entinostat	Investigational	RPL22L1	200916	upregulated	entinostat results in increased expression of RPL22L1 mRNA	3q26.2	A21037
Entinostat	Investigational	RPL31	6160	downregulated	entinostat results in decreased expression of RPL31 mRNA	2q11.2	A21037
Entinostat	Investigational	RPP25	54913	upregulated	entinostat results in increased expression of RPP25 mRNA	15q24.2	A21037 A21035
Entinostat	Investigational	RPRD1A	55197	downregulated	entinostat results in decreased expression of RPRD1A mRNA	18q12.2	A21035
Entinostat	Investigational	RPRM	56475	upregulated	entinostat results in increased expression of RPRM mRNA	2q23.3	A21037
Entinostat	Investigational	RPRML	388394	upregulated	entinostat results in increased expression of RPRML mRNA	17q21.32	A21037
Entinostat	Investigational	RPS15A	6210	downregulated	entinostat results in decreased expression of RPS15A mRNA	16p12.3	A21037
Entinostat	Investigational	RPS24	6229	upregulated	entinostat results in increased expression of RPS24 mRNA	10q22.3	A21037
Entinostat	Investigational	RRAD	6236	upregulated	entinostat results in increased expression of RRAD mRNA	16q22.1	A21035
Entinostat	Investigational	RRAGD	58528	upregulated	entinostat results in increased expression of RRAGD mRNA	6q15	A21035
Entinostat	Investigational	RRAS	6237	upregulated	entinostat results in increased expression of RRAS mRNA	19q13.33	A21035
Entinostat	Investigational	RRBP1	6238	upregulated	entinostat results in increased expression of RRBP1 mRNA	20p12.1	A21037
Entinostat	Investigational	RSPH1	89765	downregulated	entinostat results in decreased expression of RSPH1 mRNA	21q22.3	A21037
Entinostat	Investigational	RSPH1	89765	upregulated	entinostat results in increased expression of RSPH1 mRNA	21q22.3	A21035
Entinostat	Investigational	RSPH9	221421	upregulated	entinostat results in increased expression of RSPH9 mRNA	6p21.1	A21035
Entinostat	Investigational	RSPO2	340419	downregulated	entinostat results in decreased expression of RSPO2 mRNA	8q23.1	A21037
Entinostat	Investigational	RTN1	6252	downregulated	entinostat results in decreased expression of RTN1 mRNA	14q23.1	A21037
Entinostat	Investigational	RTN4IP1	84816	upregulated	entinostat results in increased expression of RTN4IP1 mRNA	6q21	A21037
Entinostat	Investigational	RTP1	132112	upregulated	entinostat results in increased expression of RTP1 mRNA	3q27.3	A21037
Entinostat	Investigational	RUBCN	9711	downregulated	entinostat results in decreased expression of RUBCN mRNA	3q29	A21037
Entinostat	Investigational	RUBCNL	80183	upregulated	entinostat results in increased expression of RUBCNL mRNA	13q14.13	A21035

Displaying entries 38376 - 38400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability